Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
12/2012
12/26/2012CN102838602A 培美曲塞氧化物及其制备方法 Pemetrexed oxide and its preparation method
12/26/2012CN102838511A Sitagliptin intermediates as well as preparation method and application of intermediate
12/25/2012US8338614 e.g. 2-[5-(5-methyl-1,3-diphenyl-1H-pyrazol-4-yl)-1,3,4-oxadiazol-2-yl]-1-phenylpropan-2-amine; neurodegenerative diseases; preventing the formation of insoluble amyloid beta and arresting the production of amyloid beta
12/25/2012US8338604 Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors
12/25/2012US8338596 Process for the preparation of 5-substituted-8-alkoxy[1,2,4]triazolo[1,5-c]pyrimidin-2-amines
12/25/2012US8338595 Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
12/25/2012US8338594 Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
12/25/2012US8338472 Hexahydrocyclopentyl[F]indazole carboxamides and derivatives thereof as selective glucocorticoid receptor modulators
12/25/2012US8338440 Inhibitors of IAP
12/25/2012US8338437 Amines as small molecule inhibitors
12/25/2012US8338436 Amorphous form of N-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a]pyrimidin-7-yl]-phenyl}-N-methyl-acetamide
12/25/2012US8338422 Indolin-2-ones and aza-indolin-2-ones
12/25/2012US8338412 Inhibitors of P38
12/20/2012WO2012174379A2 Polyhedral cage-containing metalloporphyrin frameworks, methods of making, and methods of using
12/20/2012WO2012173689A2 Antimicrobial compounds and methods of making and using the same
12/20/2012WO2012173073A1 Light emitting element material and light emitting element
12/20/2012WO2012172093A1 Dihydroindolizine derivate as metabotropic glutamate receptor modulators
12/20/2012WO2012171900A1 Novel phthalazinone-pyrrolopyrimidinecarboxamide derivatives
12/20/2012WO2012171863A1 New selective ccr2 antagonists
12/20/2012WO2012171609A1 Materials for organic electroluminescent devices
12/20/2012WO2012012117A8 Fusing porphyrins with polycyclic aromatic hydrocarbons and heterocycles for optoelectric applications
12/20/2012WO2011143772A9 Inhibitors of hiv replication
12/20/2012WO2011094434A3 7-azoniabicyclo [2.2.1] heptane derivatives, methods of production, and pharmaceutical uses thereof
12/20/2012US20120323002 Imidazopyridazine compounds
12/20/2012US20120322999 Synthesis of Phosphono-Substituted Porphyrin Compounds for Attachment to Metal Oxide Surfaces
12/20/2012US20120322797 Selective beta-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents
12/20/2012US20120322793 Protein kinase inhibitors
12/20/2012US20120322791 PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS
12/20/2012US20120322790 Pyrazolopiperidine Compounds As CCR1 Receptor Antagonists
12/20/2012US20120322782 Veterinary compositions
12/20/2012US20120321967 Ionic liquid containing sulfonate ions
12/20/2012US20120318348 Organic photovoltaic-battery hybrid device
12/20/2012CA2850137A1 Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon
12/20/2012CA2837268A1 Compositions and methods for modulating a kinase
12/20/2012CA2837248A1 Novel phthalazinone -pyrrolopyrimidinecarboxamide derivatives
12/20/2012CA2833169A1 Antimicrobial compounds and methods of making and using the same
12/19/2012EP2535958A1 Organic electroluminescent element
12/19/2012EP2535957A1 Organic electroluminescent element
12/19/2012EP2535340A2 Process for making zilpaterol and salts thereof
12/19/2012EP2535331A1 Condensed-Cyclic Compound and Organic Light-Emitting Diode Comprising the Same
12/19/2012EP2534155A1 Compounds for treating respiratory syncytial virus infections
12/19/2012EP2534154A1 Macrocycles as factor xia inhibitors
12/19/2012EP2534153A1 Salts and polymorphs of 8-fluoro-2-{4-[(methylamino}methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
12/19/2012EP2534152A1 Macrocycles as factor xia inhibitors
12/19/2012EP2534151A1 8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds
12/19/2012EP2534137A1 Pyridazine derivatives useful as cannabinoid - 2 agonists
12/19/2012CN1984915B Adduct of fluorescent dye and tumor avid tetrapyrrole
12/19/2012CN102834513A Antiviral therapeutic agents
12/19/2012CN102834506A Method for producing regulatory dendritic cells
12/19/2012CN102834397A Macrocycles as factor xia inhibitors
12/19/2012CN102834396A Aryl - /heteroaryl - cyclohexenyl - tetraazabenzo [e] azulenes as vasopressin antagonists
12/19/2012CN102834387A Phenylpyri(mi)dinylpyrazoles and their use as fungicides
12/19/2012CN102827169A Novel porphyrin ligand and metal complex, preparation method and application for novel porphyrin ligand
12/19/2012CN102827168A Preparation method of pemetrexed intermediate
12/19/2012CN102827167A Octahydro-pyrrolo[3,4-b]pyrrole derivatives and use of octahydro-pyrrolo[3,4-b]pyrrole derivatives as histamine-3 receptor
12/19/2012CN102827143A Novel synthetic method for fluoroquinolone and salts thereof
12/19/2012CN102827142A Quinoline-8-formamide compound as well as preparation method and applications thereof
12/19/2012CN102827078A Condensed-cyclic compound and organic light-emitting diode comprising the same
12/19/2012CN102824383A Method for extracting madagascar periwinkle herb total alkaloid
12/18/2012US8334379 Process for producing imidazo[1,2-b]pyridazine compound
12/18/2012US8334377 Porphyrin catalysts and methods of use thereof
12/18/2012CA2720944C Compounds and compositions as kinase inhibitors
12/18/2012CA2677572C 3-amino-pyrrolo[3,4-c]pyrazole-5(1h,4h,6h) carbaldehyde derivatives as pkc inhibitors
12/18/2012CA2661354C New small molecule inhibitors of mdm2 and the uses thereof
12/18/2012CA2631732C Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
12/18/2012CA2577758C Gyrase inhibitors and uses thereof
12/18/2012CA2517517C P38 inhibitors and methods of use thereof
12/15/2012CA2834497A1 New hexahydropyrroloimidazolone compounds
12/13/2012WO2012171016A1 Organic compounds
12/13/2012WO2012170845A2 Metabotropic glutamate receptor 5 modulators and methods of use thereof
12/13/2012WO2012169821A1 Novel compounds for organic electronic material and organic electroluminescent device using the same
12/13/2012WO2012168817A1 Pyrazolo[3,4-d]pyrimidine compounds and their use as pde2 inhibitors and/or cyp3a4 inhibitors
12/13/2012WO2012168733A1 Substituted 8 - amino - imidazo [1, 2-a] pyrazines as antibacterial agents
12/13/2012WO2012167415A1 Pyrimidopyrimidone derivatives, pharmaceutical compositions and uses thereof
12/13/2012WO2012151525A9 Novel compounds as modulators of protein kinases
12/13/2012WO2012015677A9 6-(1-methyl-1h-pyrazol-4-yl)-3-(2-methyl-2h-indazol-5-ylthio)-[1,2,4] triazolo [4,3-b] pyridazine as a c-met inhibitor
12/13/2012US20120316335 Pyrrolo[2,l-c][l,4]benzodiazepine-benzothiazole or benzoxazole conjugates linked through piperazine moiety and process for the preparation thereof
12/13/2012US20120316186 Deazapurines useful as inhibitors of janus kinases
12/13/2012US20120316185 Cyclohexyl Amide Derivatives as CRF Receptor Antagonists
12/13/2012US20120316176 DERIVATIVES OF 7,8-DIHYDRO-1H-IMIDAZO[2,1-b] PURIN-4(5H)-ONE and METHODS OF USE THEREOF
12/13/2012US20120316175 Solid state forms of sitagliptin salts
12/13/2012US20120316161 Novel antiviral compounds
12/13/2012US20120316159 Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments
12/13/2012US20120316150 Amide compounds useful in therapy
12/13/2012US20120316148 Compositions and Methods for Modulating a Kinase
12/13/2012CA2838885A1 Pyrimido[4,5-d]pyrimidinyl compounds, pharmaceutical compositions and use thereof
12/13/2012CA2837883A1 Metabotropic glutamate receptor 5 modulators and methods of use thereof
12/13/2012CA2836851A1 Pyrazolo[3,4-d]pyrimidine compounds and their use as pde2 inhibitors and/or cyp3a4 inhibitors
12/12/2012EP2532667A1 Deazapurines useful as inhibitors of janus kinases
12/12/2012EP2532666A1 Pharmaceutically acceptable salts of pyrrolo-nitrogenous heterocyclic derivatives, preparation method and medical use thereof
12/12/2012EP2532665A1 Benzimidazole derivatives and pharmaceutical compositions and uses thereof
12/12/2012EP2532659A1 Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy
12/12/2012EP2532658A1 Therapeutic agent for cerebral infarction
12/12/2012EP2532235A1 Inhibitors of bruton's tyrosine kinase
12/12/2012EP2532234A1 Inhibitors of bruton's tyrosine kinase
12/12/2012EP2531509A1 Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
12/12/2012EP2531508A1 Pyrrolo [ 2, 3 - d]pyrimidine urea compounds as jak inhibitors
12/12/2012EP2531507A1 Crystalline forms of (s)-1-(4-(5-cyclopropyl-1h-pyrazol-3- ylamino)pyrrolo [1,2-f][1,2,4]triazin-2-yl)-n-(6-fluoropyridin- 3-yl)-2-methylpyrrolidine-2-carboxamide
12/12/2012EP2531503A1 Gamma secretase modulaters
12/12/2012EP2531492A1 1,2,4-triazine-4-amine derivatives
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 573